Schedule 13G ownership disclosure

Amicus Therapeutics Inc

Common Stock · CUSIP: 03152W109

Event date: 2025-11-28

Filing-level shares
30,871,374
Percent of class
10%
  • The Vanguard Group

    Shares: 30,871,374 · Class: 10%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000373
Form type
SCHEDULE 13G/A
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Dec 03, 2025
Reporting period
Nov 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub